加强通知驱动的联系,以照顾昆士兰州丙型肝炎患者:系统限制和解决方案。

IF 1.6 Q3 Medicine
Amanda E Armstrong, Stephen B Lambert, Theophilus I Emeto, Janet Farmer, Catherine Quagliotto
{"title":"加强通知驱动的联系,以照顾昆士兰州丙型肝炎患者:系统限制和解决方案。","authors":"Amanda E Armstrong, Stephen B Lambert, Theophilus I Emeto, Janet Farmer, Catherine Quagliotto","doi":"10.33321/cdi.2025.49.035","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Achieving the World Health Organization's 2030 hepatitis C virus (HCV) elimination goals necessitates robust and outcome-focussed surveillance. In Australia, HCV is a nationally notifiable condition, with state and territory health authorities leading surveillance and public health response. This study aimed to examine Queensland's HCV surveillance system and to identify barriers to, and solutions for, implementing notification-driven linkage to care.</p><p><strong>Methods: </strong>This study was conducted in two parts. System mapping and gap identification were conducted through consultation with key stakeholders operationally involved in HCV surveillance. Secondly, a proof-of-concept descriptive analysis of two months of notification data (January to February 2023), coinciding with a period of enhanced surveillance work, was conducted to scope the magnitude of follow-up and to provide insights into groups needing targeted support. Cases were grouped into indeterminate, active and cleared categories.</p><p><strong>Results: </strong>System mapping and gap analysis identified significant constraints, including the absence of automated data processes and key data elements. These factors impeded the implementation of surveillance case definitions and hindered the identification of priority groups for linkage to care. Of 2,257 cases, 1,218 (54.0%) were individuals who had cleared HCV infection. There were 305 cases with incomplete diagnostic testing; 92/305 (30.2%) were Aboriginal and/or Torres Strait Islander people. Incomplete diagnostic testing was significantly more likely to occur for cases tested in the community compared to those tested in a correctional setting (<i>p</i> < 0.001). Of 734 active cases, 83.1% were male, 53.3% were tested in corrections, and 36.0% were Aboriginal and/or Torres Strait Islander people.</p><p><strong>Conclusion: </strong>To strengthen Queensland's HCV surveillance and enable effective linkage to care, several recommendations are proposed. These include amending public health regulations to require negative HCV RNA testing notification; establishing systematic real-time or close to real-time linkage of related datasets, including treatment data; automating the reporting of Point of Care Testing results; implementing a HCV clearance cascade; and adopting a centralised state-wide public health model. Addressing these barriers will be essential to achieving optimal HCV surveillance and care in Queensland.</p>","PeriodicalId":36867,"journal":{"name":"Communicable diseases intelligence (2018)","volume":"49 ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Enhancing notification-driven linkage to care for people living with hepatitis C in Queensland: system constraints and solutions.\",\"authors\":\"Amanda E Armstrong, Stephen B Lambert, Theophilus I Emeto, Janet Farmer, Catherine Quagliotto\",\"doi\":\"10.33321/cdi.2025.49.035\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Achieving the World Health Organization's 2030 hepatitis C virus (HCV) elimination goals necessitates robust and outcome-focussed surveillance. In Australia, HCV is a nationally notifiable condition, with state and territory health authorities leading surveillance and public health response. This study aimed to examine Queensland's HCV surveillance system and to identify barriers to, and solutions for, implementing notification-driven linkage to care.</p><p><strong>Methods: </strong>This study was conducted in two parts. System mapping and gap identification were conducted through consultation with key stakeholders operationally involved in HCV surveillance. Secondly, a proof-of-concept descriptive analysis of two months of notification data (January to February 2023), coinciding with a period of enhanced surveillance work, was conducted to scope the magnitude of follow-up and to provide insights into groups needing targeted support. Cases were grouped into indeterminate, active and cleared categories.</p><p><strong>Results: </strong>System mapping and gap analysis identified significant constraints, including the absence of automated data processes and key data elements. These factors impeded the implementation of surveillance case definitions and hindered the identification of priority groups for linkage to care. Of 2,257 cases, 1,218 (54.0%) were individuals who had cleared HCV infection. There were 305 cases with incomplete diagnostic testing; 92/305 (30.2%) were Aboriginal and/or Torres Strait Islander people. Incomplete diagnostic testing was significantly more likely to occur for cases tested in the community compared to those tested in a correctional setting (<i>p</i> < 0.001). Of 734 active cases, 83.1% were male, 53.3% were tested in corrections, and 36.0% were Aboriginal and/or Torres Strait Islander people.</p><p><strong>Conclusion: </strong>To strengthen Queensland's HCV surveillance and enable effective linkage to care, several recommendations are proposed. These include amending public health regulations to require negative HCV RNA testing notification; establishing systematic real-time or close to real-time linkage of related datasets, including treatment data; automating the reporting of Point of Care Testing results; implementing a HCV clearance cascade; and adopting a centralised state-wide public health model. Addressing these barriers will be essential to achieving optimal HCV surveillance and care in Queensland.</p>\",\"PeriodicalId\":36867,\"journal\":{\"name\":\"Communicable diseases intelligence (2018)\",\"volume\":\"49 \",\"pages\":\"\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-07-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Communicable diseases intelligence (2018)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33321/cdi.2025.49.035\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communicable diseases intelligence (2018)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33321/cdi.2025.49.035","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

导论:实现世界卫生组织2030年消除丙型肝炎病毒(HCV)的目标需要强有力的、以结果为重点的监测。在澳大利亚,丙型肝炎病毒是一种全国应通报的疾病,由州和地区卫生当局领导监测和公共卫生应对。本研究旨在检查昆士兰州的HCV监测系统,并确定实施通知驱动的护理联系的障碍和解决方案。方法:本研究分为两部分进行。通过与实际参与丙型肝炎病毒监测的主要利益攸关方协商,进行了系统制图和差距识别。其次,在加强监测工作期间,对两个月的通报数据(2023年1月至2月)进行了概念验证描述性分析,以确定后续行动的规模,并为需要有针对性支持的群体提供见解。病例分为不确定、活动和清除三类。结果:系统映射和差距分析确定了重要的限制,包括缺乏自动化数据处理和关键数据元素。这些因素阻碍了监测病例定义的实施,并阻碍了确定与护理联系的重点群体。在2257例病例中,1218例(54.0%)是已清除HCV感染的个体。诊断检测不完全的305例;92/305(30.2%)为土著和/或托雷斯海峡岛民。不完全诊断检测在社区检测的病例明显比在矫正环境中检测的病例更容易发生(p < 0.001)。在734例活跃病例中,83.1%为男性,53.3%为矫正检查,36.0%为土著和/或托雷斯海峡岛民。结论:为了加强昆士兰州的HCV监测并使其与护理有效联系,提出了几项建议。这些措施包括修订公共卫生条例,要求通报丙型肝炎病毒RNA检测呈阴性;建立系统的实时或接近实时的相关数据集链接,包括治疗数据;自动报告护理点测试结果;实施HCV级联清除;采取集中的全州公共卫生模式。解决这些障碍对于在昆士兰州实现最佳的HCV监测和护理至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Enhancing notification-driven linkage to care for people living with hepatitis C in Queensland: system constraints and solutions.

Introduction: Achieving the World Health Organization's 2030 hepatitis C virus (HCV) elimination goals necessitates robust and outcome-focussed surveillance. In Australia, HCV is a nationally notifiable condition, with state and territory health authorities leading surveillance and public health response. This study aimed to examine Queensland's HCV surveillance system and to identify barriers to, and solutions for, implementing notification-driven linkage to care.

Methods: This study was conducted in two parts. System mapping and gap identification were conducted through consultation with key stakeholders operationally involved in HCV surveillance. Secondly, a proof-of-concept descriptive analysis of two months of notification data (January to February 2023), coinciding with a period of enhanced surveillance work, was conducted to scope the magnitude of follow-up and to provide insights into groups needing targeted support. Cases were grouped into indeterminate, active and cleared categories.

Results: System mapping and gap analysis identified significant constraints, including the absence of automated data processes and key data elements. These factors impeded the implementation of surveillance case definitions and hindered the identification of priority groups for linkage to care. Of 2,257 cases, 1,218 (54.0%) were individuals who had cleared HCV infection. There were 305 cases with incomplete diagnostic testing; 92/305 (30.2%) were Aboriginal and/or Torres Strait Islander people. Incomplete diagnostic testing was significantly more likely to occur for cases tested in the community compared to those tested in a correctional setting (p < 0.001). Of 734 active cases, 83.1% were male, 53.3% were tested in corrections, and 36.0% were Aboriginal and/or Torres Strait Islander people.

Conclusion: To strengthen Queensland's HCV surveillance and enable effective linkage to care, several recommendations are proposed. These include amending public health regulations to require negative HCV RNA testing notification; establishing systematic real-time or close to real-time linkage of related datasets, including treatment data; automating the reporting of Point of Care Testing results; implementing a HCV clearance cascade; and adopting a centralised state-wide public health model. Addressing these barriers will be essential to achieving optimal HCV surveillance and care in Queensland.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
72
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信